• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 15
  • 14
  • 6
  • 2
  • 1
  • Tagged with
  • 38
  • 38
  • 38
  • 11
  • 10
  • 10
  • 9
  • 9
  • 9
  • 9
  • 9
  • 9
  • 9
  • 8
  • 8
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
31

Novo papel da galectina-1 como molécula efetora de células citotóxicas. / New role for galectin-1 as effector molecule of cytotoxic cells.

Tiago Clemente Machado 18 March 2014 (has links)
A exocitose de grânulos secretórios é o principal mecanismo efetor de células TCD8+. No entanto, pouco se sabe sobre a composição dos grânulos líticos dessas células. Resultados prévios do nosso grupo identificaram algumas dezenas de novas proteínas desses grânulos. Dentre elas foi identificada Gal-1. A literatura relata que Gal-1 age por via exógena através de sua secreção por via não convencional. Dados iniciais do nosso grupo apontam um novo cenário para esta proteína no qual ela está presente em grânulos citotóxicos. Através das técnicas de microscopia eletrônica e confocal e de ensaios de citotoxicidade, nossos resultados sugerem que Gal-1 participa do papel citotóxico das CTLs modulando a via dos receptores de morte FAS-FASL. Nós também mostramos que Gal-1 interfere com o tempo de contato entre APCs e linfócitos TCD8+, com a ativação dessas células e com o controle da proliferação dos linfócitos. Nossos resultados apontam um novo cenário para Gal-1, no qual ela está presente em grânulos líticos das CTLs e está relacionada a resposta efetora dessas células. / Exocytosis of secretory granules is the main effector mechanism of CD8+ T cells. In particular, little is known about CTLs lytic granules composition. Previous results from our group identified a few dozens of new proteins associated with these granules. Among them, we identified galectin-1. Literature reports the extracellular action of Gal-1. Initial data from our group suggested a new scenario for this protein, since Gal-1 was found inside cytotoxic granules. Here, we show by transmission electron and confocal laser scanning microscopy and cytotoxicity assays that Gal-1 has a role on CTL killing probably mediating the FAS-FASL pathway. We also show that Gal-1 is regulates the time of contact between APCs and TCD8+ lymphocytes, the activation of APCs and the proliferation of CD8 T cells. Taken together, our findings suggest a new scenario, in which Gal-1 is present in CTL granules and participates in cytotoxic effector response.
32

Étude de la différenciation des lymphocytes T CD8+ effecteurs et mémoires : rôle de la cellule présentatrice d’antigène et de la voie de signalisation Notch

Mathieu, Mélissa 09 1900 (has links)
Lors d’une infection par un pathogène, des lymphocytes T CD8+ naïfs (LTn) spécifiques de l’antigène sont activés, prolifèrent et se différencient en LT effecteurs (LTe). Les LTe produisent différentes cytokines et acquièrent une activité cytotoxique menant à l’élimination du pathogène. Seulement 5 à 10 % des LTe survivront et se différencieront en LT mémoires (LTm), qui sont capables de répondre plus rapidement lors d’une seconde infection par le même pathogène, contribuant au succès de la vaccination. Toutefois, la compréhension de l’ensemble des mécanismes régulant le développement des LTe et des LTm demeure incomplète. Afin de mieux comprendre les signaux requis pour la différenciation des LT CD8+ lors de la réponse immune, nous avons posé deux hypothèses. Nous avons d’abord proposé que différentes cellules présentatrices d’antigène (CPA) fournissent différents signaux au moment de la reconnaissance antigénique influençant ainsi le devenir des LT CD8+. Vu leur potentiel d’utilisation en immunothérapie, nous avons comparé la capacité d’activation des LT CD8+ par les lymphocytes B activés via le CD40 (CD40-B) et les cellules dendritiques (CD). Nous avons montré que l’immunisation avec des CD40-B induit une réponse effectrice mais, contrairement à l’immunisation avec des CD, pratiquement aucun LTm n’est généré. Les LTe générés sont fonctionnels puisqu’ils sécrètent des cytokines, ont une activité cytotoxique et contrôlent une infection avec Listeria monocytogenes (Lm). Nous proposons qu’une sécrétion plus faible de cytokines par les CD40 B ainsi qu’une interaction plus courte et moins intime avec les LT CD8+ comparativement aux CD contribuent au défaut de différenciation des LTm observé lors de la vaccination avec les CD40-B. Ensuite, nous posé l’hypothèse que, parmi les signaux fournis par les CPA au moment de la reconnaissance antigénique, la voie de signalisation Notch influence le développement des LTe, mais aussi des LTm CD8+ en instaurant un programme génétique particulier. D’abord, grâce à un système in vitro, le rôle de la signalisation Notch dans les moments précoces suivant l’activation du LT CD8+ a été étudié. Ce système nous a permis de démontrer que la voie de signalisation Notch régule directement l’expression de la molécule PD-1. Ensuite, grâce à des souris où il y a délétion des récepteurs Notch1 et Notch2 seulement chez les LT CD8+ matures, un rôle de la voie de signalisation Notch dans la réponse immune des LT CD8+ a été démontré. Nos résultats démontrent que suite à une infection avec Lm ou à une immunisation avec des CD, la signalisation Notch favorise le développement de LTe, exprimant fortement KLRG1 et faiblement CD127, destinés à mourir par apoptose. Toutefois, la signalisation Notch n’a pas influencé la génération de LTm. De façon très intéressante, l’expression des récepteurs Notch influence la production d’IFN- en fonction du contexte d’activation. En effet, suite à une infection avec Lm, l’absence des récepteurs Notch n’affecte pas la production d’IFN- par les LTe, alors qu’elle est diminuée suite à une immunisation avec des CD suggérant un rôle dépendant du contexte pour la voie de signalisation Notch. Nos résultats permettent une meilleure compréhension des signaux fournis par les différentes CPA et de la voie de signalisation Notch, donc des mécanismes moléculaires régulant la différenciation des LT CD8+ lors de la réponse immunitaire, ce qui pourrait ultimement permettre d’améliorer les stratégies de vaccination. / Following an infection with a pathogen, antigen-specific naive CD8+ T lymphocytes (Tn) will proliferate and differentiate into effector (Te) cells. Those Te cells will produce different cytokines and acquire a cytotoxic activity, leading to pathogen clearance. Only 5 to 10 % of Te cells will survive and differentiate into memory CD8+ T lymphocytes (Tm) able to respond rapidly following a second encounter with the same pathogen, contributing to the success of vaccination. However, the mechanisms regulating Te and Tm cells development remain incompletely understood. To better understand the signals required for CD8+ T lymphocytes during an immune response, we proposed two hypotheses. First, we propose that different antigen presenting cells (APCs) can deliver different signals to CD8+ T lymphocytes at the time of priming leading to different outcome. Given their potential for use in immunotherapy, we compared the ability of CD40 activated B lymphocytes (CD40-B) and dendritic cells (DCs) to activate CD8+ T lymphocytes. We have shown that CD40-B cell immunisation leads to an effector response but very few Tm cells are generated compared to DC immunisation. The Te cells generated following CD40-B cell immunisation are functional because they secrete cytokine, are cytotoxic and control a Listeria monocytogenes (Lm) infection. We propose that CD40-B cells secrete less cytokines and interact during shorter period of time with the CD8+ T lymphocytes, without engulfment, contributing to the decreased Tm generation observed following immunisation with CD40-B cells. Second, among the signals provided by APC at the time of CD8+ T lymphocyte priming, we have hypothesised that the Notch signalling pathway influences Te and Tm cell differentiation by inducing a particular genetic program. Using an in vitro system, we first studied the role of the Notch signalling pathway in the hours following CD8+ T lymphocyte priming. We demonstrated that Notch signalling directly regulates PD-1 expression. Then, studying mice where Notch1 and Notch2 receptor genes are deleted only in mature CD8+ T lymphocytes, we characterised the role of the Notch signalling pathway on Te and Tm differentiation during an immune response. Our results show that following Lm infection or a DC immunisation, the Notch signalling pathway promotes the differentiation of short lived effector cells Te cells (KLRG1highCD127low) meant to die by apoptosis. However, the Notch signalling pathway did not influence the generation of CD8+ Tm cells. Most interestingly, IFN- regulation by the Notch signalling pathway depends on the activation context. Indeed, following Lm infection, lack of Notch receptors does not impact IFN- secretion by Te cells while it is significantly decreased following a DC immunisation suggesting a context dependant role for the Notch signalling pathway. Our findings provide a better understanding of the key signals provided by APC as well as the Notch signalling pathway, and thus the molecular mechanisms leading to CD8+ lymphocyte effector and memory generation which is crucial as this knowledge may ultimately lead to improved vaccination.
33

Expressão de microRNAs em indivíduos com infecção assintomática e com mielopatia associada ao HTLV-1/paraparesia espástica tropical (HAM/TSP) / MicroRNA expression in HTLV-1 asymptomatic carriers and in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)

Costa, Emanuela Avelar Silva 20 October 2016 (has links)
Embora o vírus linfotrópico de células T humanas do tipo 1 (HTLV-1) seja reconhecido como o agente etiológico da leucemia/linfoma de células T do adulto (ATL) e da paraparesia espástica tropical/mielopatia associada ao HTLV-1 (HAM/TSP), cerca de 90% dos indivíduos infectados permanecem assintomáticos por toda a vida. Até o presente momento, os fatores associados ao desenvolvimento de doença relacionada ao HTLV-1 não foram totalmente elucidados. Sabe-se que o aumento da carga proviral e a expressão de genes virais estão envolvidos no desenvolvimento/progressão de doenças associadas ao HTLV-1. Assim, por exemplo, a proteína Tax modula genes envolvidos na patogênese da HAM/TSP e genes regulados por HBZ estimulam a proliferação de linfócitos T, induzindo a ATL. Desde a última década, diversos estudos têm demonstrado que células transformadas pelo HTLV-1 apresentam microRNAs do hospedeiro desregulados, o que poderia promover alteração na expressão de genes virais (tax e HBZ), com possível contribuição para o desenvolvimento de HAM/TSP e ATL. Diante desses indícios, o presente estudo teve como objetivos: i) quantificar a expressão de miRNAs humanos conhecidos em células T CD4+ e T CD8+ do sangue periférico de indivíduos assintomáticos infectados por HTLV-1 e de pacientes com HAM/TSP; ii) identificar padrões diferenciais de expressão de miRNAs desregulados que pudessem caracterizar os grupos de pacientes de acordo com sua condição clínica; iii) investigar associações dos padrões diferenciais de expressão de miRNAs com a carga proviral e com a expressão dos genes tax e HBZ de HTLV-1. Analisou-se o perfil de expressão de 754 miRNAs em células T CD4+ e TCD8+ infectadas por HTLV-1 em 19 indivíduos assintomáticos, 17 pacientes com HAM/TSP e 14 controles não infectados. Foram detectados 10 miRNAs diferencialmente expressos no grupo HAM, quando comparados ao grupo ASS (super-expressos: hsa-miR-133a, -148a, -211, -330, -369-5p, -486 e -889 e sub-expressos: hsa-miR-520b, -520e e -566). A expressão alterada dos hsa-miR-133a, -148a, -211, e -889 (super-expressos) e do hsa-miR-520b (sub-expresso) foi correlacionada à carga proviral e a do hsa-miR-211 (super-expresso) à expressão de tax. Além disso, ao analisar as vias canônicas geradas no estudo, identificaram-se as moléculas IL6ST, PTPN11, MAP2K5, ELK4, AKT1, BAD, FOSL1, IRAK 3, CDC42, STAT3 e CREB A como potencialmente afetadas pela expressão alterada de miRNAs no grupo HAM, quando comparado com o grupo ASS. Tais achados mostram-se úteis para o delineamento futuro de estudos longitudinais com indivíduos infectados por HTLV-1, com vistas à identificação de biomarcadores prognósticos de risco para o desenvolvimento de HAM/TSP. / Even though human lymphotropic virus type 1 (HTLV-1) is etiologically linked to adult T-cell leukemia (ATL) and to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), about 90% of infected individuals remain asymptomatic lifelong. So far, factors that are associated with development of HTLV-1-related disease have not been totally clarified. Increase in proviral load and expression of viral genes are recognized as involved in disease development and progression. For instance, the Tax protein is known to modulate genes that are involved in HAM/TSP pathogenesis and HBZ-regulated genes account for T lymphocyte proliferation that leads to ATL. In the last decade, several studies have shown that HTLV-1-transformed cells exhibit dysregulated human microRNA expression, which could result in altered viral gene expression (tax and HBZ), contributing to the development of HAM/TSP and ATL. Based on this evidence, our study aimed at: i) quantifying known human miRNA expression in CD4+ and CD8+ peripheral blood T-cells from HTLV-1 asymptomatic carriers and patients with HAM/TSP; ii) identifying distinctive dysregulated miRNA expression profiles that could distinguish patients according to their clinical status; iii) investigating associations between differential miRNA expression profiles with proviral load and with HTLV-1 tax and HBZ gene expression. We analysed the expression profile of 754 miRNAs in CD4+ e CD8+ peripheral blood T cells from 19 HTLV-1 asymptomatic carriers (AC), 17 patients with HAM/TSP (HAM) and in 14 non-infected controls. Ten differentially expressed miRNAs were found in HAM, as compared with AC (overexpressed: hsa-miR-133a, -148a, -211, -330, -369-5p, -486 and -889; and underexpressed: hsa-miR-520b, -520e and -566). Altered expression of hsa-miR-133a, -148a, -211, and -889 (overexpressed) and of hsa-miR-520b (underexpressed) was shown to be correlated with proviral load and that of hsa-miR-211 (overexpressed) with tax expression. Moreover, analysing the miRNA canonical pathways generated in this study, we identified IL6ST, PTPN11, MAP2K5, ELK4, AKT1, BAD, FOSL1, IRAK 3, CDC42, STAT3 and CREB A as molecules that are potentially affected by altered miRNA expression in HAM, as compared to AC. Our findings are useful for the future design of longitudinal studies of HTLV-1 infected cohorts, aiming at the recognition of prognostic biomarkers of risk for the development of HAM/TSP
34

Expressão de microRNAs em indivíduos com infecção assintomática e com mielopatia associada ao HTLV-1/paraparesia espástica tropical (HAM/TSP) / MicroRNA expression in HTLV-1 asymptomatic carriers and in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)

Emanuela Avelar Silva Costa 20 October 2016 (has links)
Embora o vírus linfotrópico de células T humanas do tipo 1 (HTLV-1) seja reconhecido como o agente etiológico da leucemia/linfoma de células T do adulto (ATL) e da paraparesia espástica tropical/mielopatia associada ao HTLV-1 (HAM/TSP), cerca de 90% dos indivíduos infectados permanecem assintomáticos por toda a vida. Até o presente momento, os fatores associados ao desenvolvimento de doença relacionada ao HTLV-1 não foram totalmente elucidados. Sabe-se que o aumento da carga proviral e a expressão de genes virais estão envolvidos no desenvolvimento/progressão de doenças associadas ao HTLV-1. Assim, por exemplo, a proteína Tax modula genes envolvidos na patogênese da HAM/TSP e genes regulados por HBZ estimulam a proliferação de linfócitos T, induzindo a ATL. Desde a última década, diversos estudos têm demonstrado que células transformadas pelo HTLV-1 apresentam microRNAs do hospedeiro desregulados, o que poderia promover alteração na expressão de genes virais (tax e HBZ), com possível contribuição para o desenvolvimento de HAM/TSP e ATL. Diante desses indícios, o presente estudo teve como objetivos: i) quantificar a expressão de miRNAs humanos conhecidos em células T CD4+ e T CD8+ do sangue periférico de indivíduos assintomáticos infectados por HTLV-1 e de pacientes com HAM/TSP; ii) identificar padrões diferenciais de expressão de miRNAs desregulados que pudessem caracterizar os grupos de pacientes de acordo com sua condição clínica; iii) investigar associações dos padrões diferenciais de expressão de miRNAs com a carga proviral e com a expressão dos genes tax e HBZ de HTLV-1. Analisou-se o perfil de expressão de 754 miRNAs em células T CD4+ e TCD8+ infectadas por HTLV-1 em 19 indivíduos assintomáticos, 17 pacientes com HAM/TSP e 14 controles não infectados. Foram detectados 10 miRNAs diferencialmente expressos no grupo HAM, quando comparados ao grupo ASS (super-expressos: hsa-miR-133a, -148a, -211, -330, -369-5p, -486 e -889 e sub-expressos: hsa-miR-520b, -520e e -566). A expressão alterada dos hsa-miR-133a, -148a, -211, e -889 (super-expressos) e do hsa-miR-520b (sub-expresso) foi correlacionada à carga proviral e a do hsa-miR-211 (super-expresso) à expressão de tax. Além disso, ao analisar as vias canônicas geradas no estudo, identificaram-se as moléculas IL6ST, PTPN11, MAP2K5, ELK4, AKT1, BAD, FOSL1, IRAK 3, CDC42, STAT3 e CREB A como potencialmente afetadas pela expressão alterada de miRNAs no grupo HAM, quando comparado com o grupo ASS. Tais achados mostram-se úteis para o delineamento futuro de estudos longitudinais com indivíduos infectados por HTLV-1, com vistas à identificação de biomarcadores prognósticos de risco para o desenvolvimento de HAM/TSP. / Even though human lymphotropic virus type 1 (HTLV-1) is etiologically linked to adult T-cell leukemia (ATL) and to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), about 90% of infected individuals remain asymptomatic lifelong. So far, factors that are associated with development of HTLV-1-related disease have not been totally clarified. Increase in proviral load and expression of viral genes are recognized as involved in disease development and progression. For instance, the Tax protein is known to modulate genes that are involved in HAM/TSP pathogenesis and HBZ-regulated genes account for T lymphocyte proliferation that leads to ATL. In the last decade, several studies have shown that HTLV-1-transformed cells exhibit dysregulated human microRNA expression, which could result in altered viral gene expression (tax and HBZ), contributing to the development of HAM/TSP and ATL. Based on this evidence, our study aimed at: i) quantifying known human miRNA expression in CD4+ and CD8+ peripheral blood T-cells from HTLV-1 asymptomatic carriers and patients with HAM/TSP; ii) identifying distinctive dysregulated miRNA expression profiles that could distinguish patients according to their clinical status; iii) investigating associations between differential miRNA expression profiles with proviral load and with HTLV-1 tax and HBZ gene expression. We analysed the expression profile of 754 miRNAs in CD4+ e CD8+ peripheral blood T cells from 19 HTLV-1 asymptomatic carriers (AC), 17 patients with HAM/TSP (HAM) and in 14 non-infected controls. Ten differentially expressed miRNAs were found in HAM, as compared with AC (overexpressed: hsa-miR-133a, -148a, -211, -330, -369-5p, -486 and -889; and underexpressed: hsa-miR-520b, -520e and -566). Altered expression of hsa-miR-133a, -148a, -211, and -889 (overexpressed) and of hsa-miR-520b (underexpressed) was shown to be correlated with proviral load and that of hsa-miR-211 (overexpressed) with tax expression. Moreover, analysing the miRNA canonical pathways generated in this study, we identified IL6ST, PTPN11, MAP2K5, ELK4, AKT1, BAD, FOSL1, IRAK 3, CDC42, STAT3 and CREB A as molecules that are potentially affected by altered miRNA expression in HAM, as compared to AC. Our findings are useful for the future design of longitudinal studies of HTLV-1 infected cohorts, aiming at the recognition of prognostic biomarkers of risk for the development of HAM/TSP
35

Réponse cellulaire pan-spécifique : analyse de la présentation d’antigènes conservés du virus de l’influenza

Doucet, Jean-Daniel 08 1900 (has links)
Les méthodes de vaccination actuelles contre l’influenza, axées sur la réponse à anticorps dirigée contre des antigènes hautement variables, nécessitent la production d’un vaccin pour chaque nouvelle souche. Le défi est maintenant de stimuler simultanément une réponse cellulaire pan-spécifique ciblant des antigènes conservés du virus, tel que la protéine de la matrice (M1) ou la nucléoprotéine (NP). Or, la présentation antigénique de ces protéines est peu définie chez l’humain. Nous avons analysé la présentation endogène par les complexes majeurs d’histocompatibilité de classes (CMH)-I et -II de M1 et de NP. Ainsi, les protéines M1 et NP ont été exprimées dans des cellules présentatrices d’antigènes (CPAs). Notamment, des épitopes de M1 et de NP endogènes peuvent être présentées par CMH-I et -II, ce qui résulte en une activation respectivement de lymphocytes T CD8+ et CD4+ précédemment isolés. Étant donné l’importance des lymphocytes T CD4+ dans la réponse cellulaire, nous avons cloné M1 ou NP en fusion avec des séquences de la protéine gp100 permettant la mobilisation vers les compartiments du CMH-II sans affecter la présentation par CMH-I. Des CPAs exprimant de façon endogène ces constructions modifiées ou sauvages ont ensuite été utilisées pour stimuler in vitro des lymphocytes T humains dont la qualité a été évaluée selon la production de cytokines et la présence de molécules de surface (ELISA ou marquage de cytokines intracellulaire). Nous avons observé une expansion de lymphocytes T CD8+ et CD4+ effecteurs spécifiques sécrétant diverses cytokines pro-inflammatoires (IFN-γ, TNF, MIP-1β) dans des proportions comparables avec une présentation par CMH-II basale ou améliorée. Cette qualité indépendante du niveau de présentation endogène par CMH-II de M1 et de NP des lymphocytes T CD4+ et CD8+ suggère que cette présentation est suffisante à court terme. En outre, la présentation endogène de M1 et NP a permis de stimuler des lymphocytes T spécifiques à des épitopes conservés du virus, tel qu’identifié à l’aide une méthode d’identification originale basée sur des segments d’ARNm, « mRNA PCR-based epitope chase (mPEC) ». Ensemble, ces nouvelles connaissances sur la présentation antigénique de M1 et de NP pourraient servir à établir de nouvelles stratégies vaccinales pan-spécifiques contre l’influenza. / New vaccines targeting hyper-variable influenza determinants must be prepared against every new strain. The challenge is now to develop influenza vaccines also eliciting a strong and sustained cytotoxic response against highly-conserved determinants such as the matrix (M1) and nuclear (NP) proteins. However, their antigenic presentation properties in humans are less defined. We, therefore, analyzed major histocompatibility complex class (MHC)-I and -II presentation of endogenously processed M1 and NP in human antigen presenting cells (APCs). To do so, we used APCs endogenously-expressing the M1 and NP proteins. M1 and NP epitopes can be presented by MHC-I and -II, which results in the activation of previously-isolated antigen-specific CD8+ and CD4+ T lymphocytes. Considering the importance of CD4+ T lymphocytes in the cellular immune response, we cloned M1 and NP proteins in fusion with gp100 MHC-II enhancing sequences, which do not disrupt MHC-I presentation. APCs expressing MHC-II-enhanced or wild type constructs were used to stimulate human T lymphocytes in vitro and quality of antigen presentation was evaluated on the basis of cytokine production and cell surface molecule expression (ELISA or intracellular cytokine staining). We expanded antigen-specific effector CD8+ and CD4+ T lymphocytes which secreted pro-inflammatory cytokines (IFN-γ, TNF and MIP-1β) to similar extents both with and without MHC-II enhancement. The quality of CD4+ and CD8+ T lymphocytes generated independent of the level of M1 and NP endogenous MHCII presentation suggests that this presentation is sufficient for short-term T lymphocyte stimulation. Thus, endogenous expression of M1 and NP have stimulated T lymphocytes specific to conserved influenza epitopes, as determined by an original identification technique based on mRNA segments called mRNA PCR-based epitope chase (mPEC). Overall, these new insights about T lymphocytes expanded following MHC-I and -II presentation of endogenous M1 and NP could prove useful for new complementary heterosubtypic vaccination strategies.
36

Évaluation de l'activité anti-leucémique des cellules T traitées par photodéplétion au TH9402

Cournoyer, Élise 12 1900 (has links)
No description available.
37

Réponse cellulaire pan-spécifique : analyse de la présentation d’antigènes conservés du virus de l’influenza

Doucet, Jean-Daniel 08 1900 (has links)
No description available.
38

Étude préclinique des lymphocytes T doubles-négatifs humains

Olazabal, Ainhoa 08 1900 (has links)
Les lymphocytes T CD4-CD8- (DN T, double négatif) sont une population de cellules T immunorégulatrices ayant la particularité d’inhiber les réponses immunitaires de façon spécifique à l’antigène, présentant donc un grand potentiel d’utilisation en immunothérapie. Des résultats précédents du laboratoire ont démontré sur des modèles murins qu’un transfert de cellules T DN contribuait à diminuer l’incidence du diabète de type 1 (T1D). De plus, d’autres groupes ont montré que ces cellules contribueraient également à la suppression de certaines lignées tumorales ainsi qu’à la médiation de la suppression de la maladie du greffon contre l’hôte (GVHD). L’étude présentée dans ce mémoire avait donc pour but d’évaluer le potentiel clinique des cellules DN T humaines en tant que thérapie cellulaire pour des pathologies telles que le diabète de type 1, le myélome multiple et la GVHD. Les cellules DN T circulent en très petite proportion dans le sang périphérique (1-5 %). Nous nous sommes donc penchés sur le potentiel de prolifération en culture cellulaire des cellules DN T, en développant un protocole adapté à leurs caractéristiques, qui permettrait de générer un nombre de cellules suffisant pour étudier leur phénotype et leur fonction in vitro et in vivo. Des études de cytométrie en flux ont révélé que les cellules DN T ayant subi le protocole d’activation et de culture cellulaire optimisé avaient un phénotype activé et non épuisé. De plus, des études fonctionnelles in vitro ont montré que les cellules DN T possédaient un pouvoir cytotoxique similaire aux cellules T CD8+ envers les lignées cellulaires tumorales Jurkat, NALM et RAJI. Enfin, nous avons tiré profit du modèle de souris NRG (NOD-Rag1nullIL2rgnull) pour étudier la survie en périphérie des cellules DN T humaines greffées, et leur pouvoir de prévention de la xéno-GVHD et d’un modèle de myélome multiple. L’ensemble de ces travaux a permis d’élargir les connaissances sur le phénotype et la fonction des cellules DN T chez l’humain, montrant qu’elles possèdent un potentiel thérapeutique intéressant pour certaines pathologies auto-immunes et néoplasiques en tant que thérapie cellulaire. / CD4-CD8- T lymphocytes (DN T, double negative) are a population of immunoregulatory T cells which seem to inhibit immune responses in an antigen-specific manner, and thus represent a great potential for use in immunotherapy. Previous studies in mice have shown that adoptive transfer of DN T cells decreases type 1 diabetes (T1D) incidence in otherwise autoimmune diabetes-prone mice. In addition, DN T cells also suppress the growth of certain tumor lines as well as reduce the severity of graft-versus-host disease (GVHD). The work presented in this thesis aimed to assess the clinical potential of human DN T cells as cell therapy for pathologies such as type 1 diabetes, multiple myeloma and GVHD. DN T cells compose 1 to 5% of lymphocytes in the peripheral blood. To circumvent the challenge of working with low cell numbers, we examined the proliferation potential of DN T cells in culture. Specifically, we adapted a cellular expansion protocol to their characteristics, in order to generate a sufficient number of cells to study their phenotype and their function in vitro and in vivo. Phenotypic characterization by flow cytometry revealed that DN T cells subjected to the optimized cell culture and activation protocol had an activated and not exhausted phenotype. In addition, in functional in vitro studies, DN T cells were shown to exhibit similar cytotoxic activity to CD8+ T cells, when the Jurkat, NALM and RAJI tumor cell lines were used as targets. Finally, we took advantage of the NRG mouse model (NOD-Rag1nullIL2rgnull) to study the peripheral survival of transplanted human DN T cells, and their potential to prevent xeno-GVHD and a model of multiple myeloma. All of this work has enabled us to broaden our knowledge of the phenotype and function of DN T cells in humans, showing that they have an interesting therapeutic potential for certain autoimmune and neoplastic pathologies as cell therapy.

Page generated in 0.0513 seconds